76 related articles for article (PubMed ID: 1444198)
1. Augmentation of antineoplastic effects by the combination of recombinant human tumor necrosis factor and mitoxantrone on primary culture of human ovarian cancer cells.
Cimoli G; Valenti M; Venturini M; Conte P; Russo P
Anticancer Res; 1992; 12(5):1411-4. PubMed ID: 1444198
[TBL] [Abstract][Full Text] [Related]
2. Reversal of "atypical"-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3.
Cimoli G; Valenti M; Parodi S; Mazzoni A; De Sessa F; Conte P; Russo P
Oncol Res; 1993; 5(8):311-23. PubMed ID: 8012063
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of topoisomerase inhibitor-induced DNA strand breakage and cytotoxicity by tumor necrosis factor: enhancement of topoisomerase activity as a mechanism of potentiation.
Utsugi T; Mattern MR; Mirabelli CK; Hanna N
Cancer Res; 1990 May; 50(9):2636-40. PubMed ID: 2158396
[TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant human tumor necrosis factor on A2774 human ovarian cancer cell line: potentiation of mitoxantrone cytotoxicity.
Vigani A; Chiara S; Miglietta L; Repetto L; Conte PF; Cimoli G; Morelli L; Billi G; Parodi S; Russo P
Gynecol Oncol; 1991 Apr; 41(1):52-5. PubMed ID: 2026360
[TBL] [Abstract][Full Text] [Related]
5. Potentiation by tumor necrosis factor of mitoxantrone cytotoxicity to human ovarian cancer cell lines.
Russo P; Parodi S; Billi G; Oliva C; Venturini M; Noviello E; Conte P
Jpn J Cancer Res; 1992 Jul; 83(7):684-7. PubMed ID: 1517145
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of topoisomerase I and II inhibitors cell killing by tumor necrosis factor: relationship to DNA strand breakage formation.
Orengo G; Noviello E; Cimoli G; Pagnan G; Parodi S; Venturini M; Conte P; Schenone F; Conzi G; Russo P
Jpn J Cancer Res; 1992 Nov; 83(11):1132-6. PubMed ID: 1336489
[TBL] [Abstract][Full Text] [Related]
7. Tumour necrosis factor enhances the therapeutic effect of mitoxantrone in human ovarian cancer xenograft.
Noviello E; Cimoli G; Cosimi A; Allievi E; Galletti P; Parodi S; Russo P
Cytokine; 1996 Apr; 8(4):330-3. PubMed ID: 9162224
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-induced potentiation of DNA damage and cytotoxicity in human breast cancer cells treated with topoisomerase II-interactive antitumor drugs.
Epstein RJ; Smith PJ
Cancer Res; 1988 Jan; 48(2):297-303. PubMed ID: 2825970
[TBL] [Abstract][Full Text] [Related]
9. Effect of recombinant human TNF on human ovarian cancer cell lines.
Vigani A; Miglietta L; Chiara S; Repetto L; Pichi E; Cimoli G; Morelli L; Poggi L; Billi G; Parodi S
Boll Soc Ital Biol Sper; 1990 Jun; 66(6):537-42. PubMed ID: 2257120
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunity.
Palladino MA; Shalaby MR; Kramer SM; Ferraiolo BL; Baughman RA; Deleo AB; Crase D; Marafino B; Aggarwal BB; Figari IS
J Immunol; 1987 Jun; 138(11):4023-32. PubMed ID: 3295044
[TBL] [Abstract][Full Text] [Related]
11. Effects of growth factors on the antiproliferative activity of tumor necrosis factors.
Sugarman BJ; Lewis GD; Eessalu TE; Aggarwal BB; Shepard HM
Cancer Res; 1987 Feb; 47(3):780-6. PubMed ID: 3802082
[TBL] [Abstract][Full Text] [Related]
12. [Cytotoxicity of recombinant human tumor necrosis factor (rHTNF) alone and in combination with chemotherapeutic agents on human ovarian cancer cells].
Zhao EF
Zhonghua Fu Chan Ke Za Zhi; 1993 Mar; 28(3):153-6, 188. PubMed ID: 8354095
[TBL] [Abstract][Full Text] [Related]
13. Endogenous tumor necrosis factor enhances topoisomerase II inhibitors activity in human ovarian cancer cell lines.
Debernardis D; Stanzione S; Ottoboni C; Clerico L; Mancuso T; Parodi S; Russo P
J Pharmacol Exp Ther; 1996 Oct; 279(1):84-90. PubMed ID: 8858979
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of TNF-mediated cell killing by mitoxantrone. Relationship to DNA single-strand break formation.
Valenti M; Cimoli G; Mariani GL; Conte PF; Parodi S; Russo P
Biochem Pharmacol; 1993 Oct; 46(7):1199-206. PubMed ID: 8216370
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of release of granulocyte- and granulocyte-macrophage colony-stimulating factors from phytohemagglutinin-stimulated sorted subsets of human T lymphocytes by recombinant human tumor necrosis factor-alpha. Synergism with recombinant human IFN-gamma.
Lu L; Srour EF; Warren DJ; Walker D; Graham CD; Walker EB; Jansen J; Broxmeyer HE
J Immunol; 1988 Jul; 141(1):201-7. PubMed ID: 2454257
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 4 potentiates the antiproliferative effects of tumor necrosis factor on various tumor cell lines.
Totpal K; Aggarwal BB
Cancer Res; 1991 Aug; 51(16):4266-70. PubMed ID: 1651157
[TBL] [Abstract][Full Text] [Related]
17. DNA fragmentation and cytotoxicity caused by tumor necrosis factor is enhanced by interferon-gamma.
Dealtry GB; Naylor MS; Fiers W; Balkwill FR
Eur J Immunol; 1987 May; 17(5):689-93. PubMed ID: 3108017
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the growth of transformed cells by human tumor necrosis factor-alpha and interferon-gamma.
Lewis GD; Aggarwal BB; Eessalu TE; Sugarman BJ; Shepard HM
Cancer Res; 1987 Oct; 47(20):5382-5. PubMed ID: 2820567
[TBL] [Abstract][Full Text] [Related]
19. Synergistic cytotoxic effects of tumor necrosis factor, interferon-gamma and tamoxifen on breast cancer cell lines.
Matsuo S; Takano S; Yamashita J; Ogawa M
Anticancer Res; 1992; 12(5):1575-9. PubMed ID: 1444224
[TBL] [Abstract][Full Text] [Related]
20. Lymphocytes infiltrating human ovarian tumors: synergy between tumor necrosis factor alpha and interleukin 2 in the generation of CD8+ effectors from tumor-infiltrating lymphocytes.
Wang YL; Si LS; Kanbour A; Herberman RB; Whiteside TL
Cancer Res; 1989 Nov; 49(21):5979-85. PubMed ID: 2507139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
